Related Experiment Video
Updated: Oct 17, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19
Kelly L Bolton1, Youngil Koh2,3,4, Michael B Foote5
1Department of Medicine, Washington University, St Louis, MO, USA. bolton@wustl.edu.
Insights
Clonal hematopoiesis (CH) is linked to severe COVID-19 and increased risk of bacterial infections like C. difficile. This suggests CH may predispose individuals to serious infections, warranting further study.
Area of Science:
- Hematology
- Immunology
- Infectious Diseases
Background:
- Clonal hematopoiesis (CH) involves acquired somatic mutations in hematopoietic stem cells, increasing risks for cardiovascular and malignant diseases.
- CH is associated with altered inflammatory profiles, which can worsen outcomes in infections like COVID-19.
Purpose of the Study:
- To investigate whether CH predisposes individuals to severe COVID-19.
- To examine the association between CH and the risk of other infections in patients with solid tumors.
Main Methods:
- Analysis of 525 individuals with COVID-19 from the Memorial Sloan Kettering (MSK) and Korean Clonal Hematopoiesis (KoCH) consortia.
- Examination of infection risk in 14,211 solid tumor patients at MSK with identified CH.
Main Results:
- CH was associated with severe COVID-19 outcomes (OR=1.85, p=0.01), particularly CH with non-cancer driver mutations (OR=2.01, p=0.01).
- CH significantly correlated with increased risk of Clostridium difficile (HR=2.01, p=6x10^-3) and Streptococcus/Enterococcus infections (HR=1.56, p=5x10^-3) in solid tumor patients.
Conclusions:
- CH is associated with severe COVID-19.
- CH is linked to an elevated risk of specific bacterial infections, suggesting a broader role in infection susceptibility.
Abstract:
Acquired somatic mutations in hematopoietic stem and progenitor cells (clonal hematopoiesis or CH) are associated with advanced age, increased risk of cardiovascular and malignant diseases, and decreased overall survival. These adverse sequelae may be mediated by altered inflammatory profiles observed in patients with CH. A pro-inflammatory immunologic profile is also associated with worse outcomes of certain infections, including SARS-CoV-2 and its associated disease Covid-19. Whether CH predisposes to severe Covid-19 or other infections is unknown. Among 525 individuals with Covid-19 from Memorial Sloan Kettering (MSK) and the Korean Clonal Hematopoiesis (KoCH) consortia, we show that CH is associated with severe Covid-19 outcomes (OR = 1.85, 95%=1.15-2.99, p = 0.01), in particular CH characterized by non-cancer driver mutations (OR = 2.01, 95% CI = 1.15-3.50, p = 0.01). We further explore the relationship between CH and risk of other infections in 14,211 solid tumor patients at MSK. CH is significantly associated with risk of Clostridium Difficile (HR = 2.01, 95% CI: 1.22-3.30, p = 6×10-3) and Streptococcus/Enterococcus infections (HR = 1.56, 95% CI = 1.15-2.13, p = 5×10-3). These findings suggest a relationship between CH and risk of severe infections that warrants further investigation.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Hematopoiesis
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Lineage Commitment
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

